The CV polypill strategy (acetyl salicylic acid + atorvastatin + ramipril) as baseline treatment after a cardiovascular event supported by recent compelling evidence: a global expert consensus
25 April 2024 (09:00 - 12:30)
Organised by: 
Abstract
About the speaker
Hospital de Santa Maria Faculty of Medicine, Lisbon (Portugal)
5 More presentations in this session
Access the full session
The Event
ESC Preventive Cardiology 2024
25 April 2024
09:00 CET
